Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GSK | VRTX | REGN | ||
| Company | Gsk Plc ADR | Vertex Pharmaceutic | Regeneron Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 51.52 | 423.75 | 702.56 | ||
| High | 51.61 | 428.00 | 709.99 | ||
| Low | 50.98 | 422.11 | 699.75 | ||
| Latest | 51.07 | 427.98 | 705.08 | ||
| Change | -0.54 | +4.06 | +3.66 | ||
| % Change | -1.05% | +0.96% | +0.52% | ||
| Volume | 359,303 | 98,121 | 43,583 | ||
| 20-Day Average Volume | 4,147,415 | 993,454 | 710,800 | ||
| Previous Close | 51.61 | 423.92 | 701.42 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 55.78 | 434.96 | 742.19 | ||
| 20-Day Raw Stochastic | 11.41% | 29.15% | 35.55% | ||
| 20-Day Relative Strength | 37.34 | 42.98 | 40.85 | ||
| Weighted Alpha | +32.43 | -0.42 | +27.71 | ||
| Today's Opinion | 40% Buy | 56% Sell | 24% Sell | ||
| Previous Opinion | 40% Buy | 56% Sell | 24% Sell | ||
| Last Month's Opinion | 72% Buy | 8% Buy | 48% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.79% since 04/27/26 | +0.44% since 04/27/26 | -5.06% since 04/27/26 | ||
| Low | 49.99 on 04/29/26 | 419.71 on 04/29/26 | 668.84 on 04/29/26 | ||
| High | 55.02 on 04/28/26 | 431.77 on 04/28/26 | 754.00 on 04/28/26 | ||
| 1-Month | |||||
| %Chg | -9.90% since 04/02/26 | -2.46% since 04/02/26 | -7.23% since 04/02/26 | ||
| Low | 49.99 on 04/29/26 | 419.71 on 04/29/26 | 668.84 on 04/29/26 | ||
| High | 59.57 on 04/14/26 | 447.82 on 04/15/26 | 775.63 on 04/08/26 | ||
| 3-Month | |||||
| %Chg | -10.75% since 02/04/26 | -9.06% since 02/04/26 | -8.81% since 02/04/26 | ||
| Low | 49.99 on 04/29/26 | 419.71 on 04/29/26 | 668.84 on 04/29/26 | ||
| High | 61.69 on 02/18/26 | 507.92 on 03/10/26 | 815.00 on 02/17/26 | ||
| 6-Month | |||||
| %Chg | +9.10% since 11/04/25 | +1.48% since 11/04/25 | +12.55% since 11/04/25 | ||
| Low | 45.81 on 11/20/25 | 406.67 on 11/07/25 | 628.00 on 11/05/25 | ||
| High | 61.69 on 02/18/26 | 507.92 on 03/10/26 | 821.11 on 01/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 104,726,912 | 107,828,288 | 74,154,120 | ||
| Shares Outstanding, K | 2,029,198 | 254,360 | 105,720 | ||
| Annual Sales | 43,077,970,000 | 12,001,300,000 | 14,342,900,000 | ||
| Annual Net Income | 7,537,690,000 | 3,953,200,000 | 4,504,900,000 | ||
| Last Quarter Sales | 11,424,970,000 | 3,190,000,000 | 3,884,300,000 | ||
| Last Quarter Net Income | 851,670,000 | 1,191,100,000 | 844,600,000 | ||
| 60-Month Beta | 0.38 | 0.30 | 0.30 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.24 on 04/29/26 | 5.03 on 02/12/26 | 9.47 on 04/29/26 | ||
| Earnings Date | 07/29/26 | 05/04/26 | 08/07/26 | ||
| Most Recent Dividend | 0.470 on 02/20/26 | N/A | 0.940 on 02/20/26 | ||
| Next Ex-Dividends Date | 05/15/26 | N/A | 05/20/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 11.30 | 26.03 | 19.03 | ||